Selected research
Industry Research
Oxytocin Injection Industry Research Report 2026
Market perspective
The global Oxytocin Injection market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Oxytocin Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Oxytocin Injection is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Oxytocin Injection is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Oxytocin Injection include Shanghai Hefeng, Novartis, Renjian Pharmaceutical, Pfizer, Hybio Pharmaceutical, GSK, Bayer, Kepro B.V. and JHP Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Oxytocin Injection market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Oxytocin Injection Market by Company
Shanghai Hefeng
Novartis
Renjian Pharmaceutical
Pfizer
Hybio Pharmaceutical
GSK
Bayer
Kepro B.V.
JHP Pharmaceuticals
Grindex
Bimeda
Agrilab
Oxytocin Injection Segment by Type
Oxytocin
Carbetocin
Oxytocin Injection Segment by Application
Animal Use
Human Use
Oxytocin Injection Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oxytocin Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Oxytocin Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oxytocin Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Oxytocin Injection manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Oxytocin Injection by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Oxytocin Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Oxytocin
- Carbetocin
Applications
- Animal Use
- Human Use
Companies covered
- Shanghai Hefeng
- Novartis
- Renjian Pharmaceutical
- Pfizer
- Hybio Pharmaceutical
- GSK
- Bayer
- Kepro B.V.
- JHP Pharmaceuticals
- Grindex
- Bimeda
- Agrilab
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Oxytocin Injection Market Size (2021-2032)
- 2.2.2 Global Oxytocin Injection Sales (2021-2032)
- 2.2.3 Global Oxytocin Injection Market Average Price (2021-2032)
- 2.3 Oxytocin Injection by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Oxytocin
- 2.3.3 Carbetocin
- 2.4 Oxytocin Injection by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Animal Use
- 2.4.3 Human Use
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Oxytocin Injection Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Oxytocin Injection Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Oxytocin Injection Revenue of Manufacturers (2021-2026)
- 3.4 Global Oxytocin Injection Average Price by Manufacturers (2021-2026)
- 3.5 Global Oxytocin Injection Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Oxytocin Injection, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Oxytocin Injection, Product Type & Application
- 3.8 Global Manufacturers of Oxytocin Injection, Established Date
- 3.9 Global Oxytocin Injection Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Shanghai Hefeng
- 4.1.1 Shanghai Hefeng Company Information
- 4.1.2 Shanghai Hefeng Business Overview
- 4.1.3 Shanghai Hefeng Oxytocin Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Shanghai Hefeng Oxytocin Injection Product Portfolio
- 4.1.5 Shanghai Hefeng Recent Developments
- 4.2 Novartis
- 4.2.1 Novartis Company Information
- 4.2.2 Novartis Business Overview
- 4.2.3 Novartis Oxytocin Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Novartis Oxytocin Injection Product Portfolio
- 4.2.5 Novartis Recent Developments
- 4.3 Renjian Pharmaceutical
- 4.3.1 Renjian Pharmaceutical Company Information
- 4.3.2 Renjian Pharmaceutical Business Overview
- 4.3.3 Renjian Pharmaceutical Oxytocin Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Renjian Pharmaceutical Oxytocin Injection Product Portfolio
- 4.3.5 Renjian Pharmaceutical Recent Developments
- 4.4 Pfizer
- 4.4.1 Pfizer Company Information
- 4.4.2 Pfizer Business Overview
- 4.4.3 Pfizer Oxytocin Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Pfizer Oxytocin Injection Product Portfolio
- 4.4.5 Pfizer Recent Developments
- 4.5 Hybio Pharmaceutical
- 4.5.1 Hybio Pharmaceutical Company Information
- 4.5.2 Hybio Pharmaceutical Business Overview
- 4.5.3 Hybio Pharmaceutical Oxytocin Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Hybio Pharmaceutical Oxytocin Injection Product Portfolio
- 4.5.5 Hybio Pharmaceutical Recent Developments
- 4.6 GSK
- 4.6.1 GSK Company Information
- 4.6.2 GSK Business Overview
- 4.6.3 GSK Oxytocin Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 GSK Oxytocin Injection Product Portfolio
- 4.6.5 GSK Recent Developments
- 4.7 Bayer
- 4.7.1 Bayer Company Information
- 4.7.2 Bayer Business Overview
- 4.7.3 Bayer Oxytocin Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Bayer Oxytocin Injection Product Portfolio
- 4.7.5 Bayer Recent Developments
- 4.8 Kepro B.V.
- 4.8.1 Kepro B.V. Company Information
- 4.8.2 Kepro B.V. Business Overview
- 4.8.3 Kepro B.V. Oxytocin Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Kepro B.V. Oxytocin Injection Product Portfolio
- 4.8.5 Kepro B.V. Recent Developments
- 4.9 JHP Pharmaceuticals
- 4.9.1 JHP Pharmaceuticals Company Information
- 4.9.2 JHP Pharmaceuticals Business Overview
- 4.9.3 JHP Pharmaceuticals Oxytocin Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 JHP Pharmaceuticals Oxytocin Injection Product Portfolio
- 4.9.5 JHP Pharmaceuticals Recent Developments
- 4.10 Grindex
- 4.10.1 Grindex Company Information
- 4.10.2 Grindex Business Overview
- 4.10.3 Grindex Oxytocin Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Grindex Oxytocin Injection Product Portfolio
- 4.10.5 Grindex Recent Developments
- 4.11 Bimeda
- 4.11.1 Bimeda Company Information
- 4.11.2 Bimeda Business Overview
- 4.11.3 Bimeda Oxytocin Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Bimeda Oxytocin Injection Product Portfolio
- 4.11.5 Bimeda Recent Developments
- 4.12 Agrilab
- 4.12.1 Agrilab Company Information
- 4.12.2 Agrilab Business Overview
- 4.12.3 Agrilab Oxytocin Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Agrilab Oxytocin Injection Product Portfolio
- 4.12.5 Agrilab Recent Developments
5 Global Oxytocin Injection Market Scenario by Region
- 5.1 Global Oxytocin Injection Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Oxytocin Injection Sales by Region: 2021-2032
- 5.2.1 Global Oxytocin Injection Sales by Region: 2021-2026
- 5.2.2 Global Oxytocin Injection Sales by Region: 2027-2032
- 5.3 Global Oxytocin Injection Revenue by Region: 2021-2032
- 5.3.1 Global Oxytocin Injection Revenue by Region: 2021-2026
- 5.3.2 Global Oxytocin Injection Revenue by Region: 2027-2032
- 5.4 North America Oxytocin Injection Market Facts & Figures by Country
- 5.4.1 North America Oxytocin Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Oxytocin Injection Sales by Country (2021-2032)
- 5.4.3 North America Oxytocin Injection Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Oxytocin Injection Market Facts & Figures by Country
- 5.5.1 Europe Oxytocin Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Oxytocin Injection Sales by Country (2021-2032)
- 5.5.3 Europe Oxytocin Injection Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Oxytocin Injection Market Facts & Figures by Country
- 5.6.1 Asia Pacific Oxytocin Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Oxytocin Injection Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Oxytocin Injection Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Oxytocin Injection Market Facts & Figures by Country
- 5.7.1 South America Oxytocin Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Oxytocin Injection Sales by Country (2021-2032)
- 5.7.3 South America Oxytocin Injection Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Oxytocin Injection Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Oxytocin Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Oxytocin Injection Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Oxytocin Injection Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Oxytocin Injection Sales by Type (2021-2032)
- 6.1.1 Global Oxytocin Injection Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Oxytocin Injection Sales Market Share by Type (2021-2032)
- 6.2 Global Oxytocin Injection Revenue by Type (2021-2032)
- 6.2.1 Global Oxytocin Injection Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Oxytocin Injection Revenue Market Share by Type (2021-2032)
- 6.3 Global Oxytocin Injection Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Oxytocin Injection Sales by Application (2021-2032)
- 7.1.1 Global Oxytocin Injection Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Oxytocin Injection Sales Market Share by Application (2021-2032)
- 7.2 Global Oxytocin Injection Revenue by Application (2021-2032)
- 7.2.1 Global Oxytocin Injection Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Oxytocin Injection Revenue Market Share by Application (2021-2032)
- 7.3 Global Oxytocin Injection Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Oxytocin Injection Value Chain Analysis
- 8.1.1 Oxytocin Injection Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Oxytocin Injection Production Mode & Process
- 8.2 Oxytocin Injection Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Oxytocin Injection Distributors
- 8.2.3 Oxytocin Injection Customers
9 Global Oxytocin Injection Analyzing Market Dynamics
- 9.1 Oxytocin Injection Industry Trends
- 9.2 Oxytocin Injection Industry Drivers
- 9.3 Oxytocin Injection Industry Opportunities and Challenges
- 9.4 Oxytocin Injection Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst